PT Darya-Varia Laboratoria Tbk
DVLA.JK
Get informed when a big investor buys or sells
+ FollowMarket Cap$1.78T
Close$
$4508.27
184.4% upside
Current Fair Value
184.4% upsideUndervalued by 184.4% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $1.78 Trillion |
|---|---|
| Enterprise Value | $1.30 Trillion |
| Dividend Yield | $105.00 (6.62%) |
| Earnings per Share | $146.38 |
| Beta | 0.32 |
| Outstanding Shares | 1,120,000,000 |
Return
| Return on Equity | 9.08% |
|---|---|
| Return on Assets | 5.22% |
| Return on Invested Capital | 9.95% |
Valuation & Multiples
| P/E Ratio | 13.03 |
|---|---|
| PEG | -133.27 |
| Price to Sales | 0.75 |
| Price to Book Ratio | 1.18 |
| Enterprise Value to Revenue | 0.55 |
| Enterprise Value to EBIT | 7.65 |
| Enterprise Value to Net Income | 9 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0 |
Revenue Sources
No data
Insider Trades
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About PT Darya-Varia Laboratoria Tbk
1,357 employees
CEO: Ian Martin Wibawa Kloer PT Darya-Varia Laboratoria Tbk is an Indonesian enterprise dedicated to the production and commercialization of pharmaceutical goods and cosmetic items. Its operations are organized into three primary divisions: prescription medications,...